Slingshot members are tracking this event:

Lilly (LLY)'s Clinical Efficacy, Safety and Patient-Reported Outcomes Data of Baricitinib in Patients with Rheumatoid Arthritis will be presented at 2016 American College of Rheumatology Annual Meeting, November 11-16, 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
LLY Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 14, 2016
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Baricitinib, Rheumatoid Arthritis